309 results on '"Wu, Yinuo"'
Search Results
2. Design, synthesis, and evaluation of quinolin-2(1H)-ones as PDE1 inhibitors for the treatment of inflammatory bowel disease
3. Discovery of novel selective phosphodiesterase‑1 inhibitors for the treatment of acute myelogenous leukemia
4. Discovery of highly potent phosphodiesterase-1 inhibitors by a combined-structure free energy perturbation approach
5. Gender differences in the associations between body mass index, depression, anxiety, and stress among endocrinologists in China
6. UV luminescence enhancement of Cu-doped ZnO nanorods grown by hydrothermal treatment
7. Highly Efficient Whole-Cell Biocatalysis for the Biosynthesis of 7-Methylxanthine and Other Xanthine Derivatives
8. Design, Synthesis, and Evaluation of Dihydropyrimidine Derivatives as Selective PDE1 Inhibitors for the Treatment of Liver Fibrosis
9. Circulating circTOLLIP serves as a diagnostic biomarker for liquid biopsy in non-small cell lung cancer
10. Phosphodiesterase 2 (PDE2) inhibitors: an updated patent review (2017–present)
11. Pathological Involvement of Protein Phase Separation and Aggregation in Neurodegenerative Diseases.
12. Sleep duration and satisfaction among physicians in tertiary public hospitals in China: a large sample national survey
13. The therapeutic potential of phosphodiesterase 9 (PDE9) inhibitors: a patent review (2018-present)
14. Identification of Novel Quinolin-2(1H)-ones as Phosphodiesterase 1 Inhibitors for the Treatment of Inflammatory Bowel Disease
15. Discovery and modelling studies of natural ingredients from Gaultheria yunnanensis (FRANCH.) against phosphodiesterase-4
16. Satisfaction of family members with inpatient psychiatric care and its correlates: a national survey in China
17. Accelerating and Automating the Free Energy Perturbation Absolute Binding Free Energy Calculation with the RED‑E Function.
18. Teaching Design of Basic Chemistry Based on PBL Methodology for Medical Undergraduates: A Case Study on “Osmotic Pressure of Solution”
19. Additional file 1 of Gender differences in the associations between body mass index, depression, anxiety, and stress among endocrinologists in China
20. Docking-assisted 3D-QSAR studies on xanthones as α-glucosidase inhibitors
21. Discovery of novel phosphodiesterase-1 inhibitors for curing vascular dementia: suppression of neuroinflammation by blocking NF-κB transcription regulation and activating cAMP/CREB axis
22. Structure-based discovery of orally efficient inhibitors via unique interactions with H-pocket of PDE8 for the treatment of vascular dementia
23. Structural Modifications of Nimodipine Lead to Novel PDE1 Inhibitors with Anti-pulmonary Fibrosis Effects
24. The synthesis of a new nitrogen joined N-PEG-TsDPEN ligand and its application in asymmetric transfer hydrogenation of ketones in neat water
25. Gender Differences in Burnout Among Endocrinologists in China
26. PDE1 inhibitors: a review of the recent patent literature (2008-present)
27. Gender Differences in Burnout Among Endocrinologists in China
28. Formation of a hydrothermal kaolinite deposit from rhyolitic tuff in Jiangxi, China
29. Discovery of novel phosphodiesterase-1 inhibitors for curing vascular dementia: Suppression of neuroinflammation by blocking NF-κB transcription regulation and activating cAMP/CREB axis.
30. Discovery of effective phosphodiesterase 2 inhibitors with antioxidant activities for the treatment of Alzheimer’s disease
31. A practical process to chiral ferrocenyl alcohols via asymmetric transfer hydrogenation catalyzed with a PEG-bound Ru catalyst in water and its application in preparing Ugi’s amine
32. The Prevalence and Associated Factors of Short Sleep Duration Among Nurses in Tertiary Public Hospitals in China: Findings from a National Survey
33. Structure effect of TsDPEN derivatives on enantioselectivity of asymmetric transfer hydrogenation
34. Asymmetric transfer hydrogenation of ketones with a polyethylene glycol bound Ru catalyst in water
35. Design, synthesis and evaluation of pyrazolopyrimidinone derivatives as novel PDE9A inhibitors for treatment of Alzheimer’s disease
36. Discovery of Potent Phosphodiesterase-9 Inhibitors for the Treatment of Hepatic Fibrosis
37. The Prevalence and Associated Factors of Short Sleep Duration Among Nurses in Tertiary Public Hospitals in China: Findings from a National Survey
38. Design, Synthesis, and Evaluation of Dihydropyranopyrazole Derivatives as Novel PDE2 Inhibitors for the Treatment of Alzheimer’s Disease
39. Gender Differences in Job Satisfaction and Work-Life Balance Among Chinese Physicians in Tertiary Public Hospitals
40. Discovery of Highly Specific Catalytic-Site-Targeting Fluorescent Probes for Detecting Lysosomal PDE10A in Living Cells
41. Experience of Medical Disputes, Medical Disturbances, Verbal and Physical Violence, and Burnout Among Physicians in China
42. Therapeutic targets and potential agents for the treatment of COVID‐19
43. Rational Design of 2-Chloroadenine Derivatives as Highly Selective Phosphodiesterase 8A Inhibitors
44. Discovery of highly selective and orally available benzimidazole-based phosphodiesterase 10 inhibitors with improved solubility and pharmacokinetic properties for treatment of pulmonary arterial hypertension
45. Discovery of Novel Selective and Orally Bioavailable Phosphodiesterase-1 Inhibitors for the Efficient Treatment of Idiopathic Pulmonary Fibrosis
46. Discovery and Optimization of Chromone Derivatives as Novel Selective Phosphodiesterase 10 Inhibitors
47. Research on digital restoration and redesign of Taishan stone carving
48. Discovery of Potent, Selective, and Orally Bioavailable Inhibitors against Phosphodiesterase-9, a Novel Target for the Treatment of Vascular Dementia
49. Validation of Phosphodiesterase-10 as a Novel Target for Pulmonary Arterial Hypertension via Highly Selective and Subnanomolar Inhibitors
50. Absolute Binding Free Energy Calculation and Design of a Subnanomolar Inhibitor of Phosphodiesterase-10
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.